Although polymorphisms of PD-1, PD-L1, and PD-L2 genes have been reported to associate with a high risk of cancer, to the best of our knowledge, no studies have reported PD-1, PD-L1, and PD-L2 polymorphisms in relation to primary breast cancer subtypes. This evidence concerns the gene CD274 and breast cancer.